Journal of Acute Care

Register      Login

VOLUME 3 , ISSUE 1 ( January-April, 2024 ) > List of Articles


TricValve: A Palliative Therapy for Inoperable Tricuspid Regurgitation

Uday B Khanolkar, Meemansa Kashyap Buch, Bagirath Raghuraman, Barendra Kumar Raut, Satish C Govind, Devi Prasad Shetty

Keywords : Tricuspid edge-to-edge repair, Tricuspid regurgitation, TricValve, Tricuspid valve insufficiency

Citation Information : Khanolkar UB, Buch MK, Raghuraman B, Raut BK, Govind SC, Shetty DP. TricValve: A Palliative Therapy for Inoperable Tricuspid Regurgitation. 2024; 3 (1):49-53.

DOI: 10.5005/jp-journals-10089-0109

License: CC BY-NC 4.0

Published Online: 30-04-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Patients having isolated severe tricuspid regurgitation (TR) due to primary or secondary etiology continue to suffer from right heart dysfunction with or without clinical manifestations of systemic venous congestion. They often do not respond to conventional medical therapy and show poor quality of life (QoL) outcome measures. The available options for the management of severe tricuspid valve regurgitation include surgical replacement of the tricuspid valve and/or its repair in cases undergoing concomitant left heart valve surgery, provided the patients belong to acceptable surgical risk and do not have overt right heart dysfunction (class I level C). Patients who do not qualify for surgical repair or replacement are candidates for medical management. Recent advances have introduced transcatheter options for the treatment of moderate to severe TR for improved outcomes of QoL and relief of symptoms. We present the case of a patient who underwent a TricValve implantation, which is a novel transcatheter-based heterotopic bicaval system for the management of severe functional TR.

PDF Share
  1. Besler C, Seeburger J, Thiele H, et al. Treatment options for severe functional tricuspid regurgitation: indications, techniques and current challenges. e-J Cardiol Pract 2018;16(31). Available from:
  2. Manjunath CN, Srinivas P, Ravindranath KS, et al. Incidence and patterns of valvular heart disease in a tertiary care high-volume cardiac center: a single center experience. Indian Heart J 2014;66(3):320–326. DOI: 10.1016/j.ihj.2014.03.010
  3. Sala A, Hahn RT, Kodali SK, et al. Tricuspid valve regurgitation: current understanding and novel treatment options. J Society Cardiovasc Angiograph Intervent 2023;2(5):101041. DOI: 10.1016/j.jscai.2023.101041
  4. Estévez-Loureiro R, Sánchez-Recalde A, Amat-Santos IJ, et al. 6-month outcomes of the tricvalve system in patients with tricuspid regurgitation: the TRICUS EURO study. JACC Cardiovasc Interv 2022;15(13):1366–1377. DOI: 10.1016/j.jcin.2022.05.022
  5. Wong N, Jappar IA, Ho JS, et al. Torrential tricuspid regurgitation treated with TricValve. J Asian Pacific Soc Cardiol 2022;1:e29. DOI: 10.15420/japsc.2022.11
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.